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In recent years it has been well documented that the characteristic increase in plasma lipoproteins in patients with obstructive jaundice is the result of the presence of a low-density lipoprotein (relative density 1.006-1.063 g/ml) of abnormal composition and properties. This abnormal lipoprotein has been designated "LP-X." The development of a simple immunologic test system for determining LP-X provides the basis for a new clinical chemical test that is of use in the differential diagnosis of jaundice. In this study, 2680 LP-X determinations were performed on 1481 subjects: 1309 patients with or without liver disease, and 172 healthy volunteers.
Statistical analysis of this series revealed a power of 0.99 and a specifity of 0.98 to demonstrate or exclude cholestasis. In this regard the new test is superior to other blood-chemical assessments. It was never positive in patients without liver disease. However, the LP-X test alone is not adequate to distinguish between intrahepatic cholestasis and extrahepatic biliary obstruction. having a strong tendency to aggregate (see Figure 1) ; and with a wall consisting of a phospholipid, cholesterol, and apo C. The albumin portion of LP-X seems to be masked in the core of the native particle (6, 8) .
AddItIonal Keyphrases: Plasma lipoproteins
#{149}
It has been proposed (6) , that the specific corn bination of apo C and albumin plays an important role in maintaining the structural integrity of this lipoprotein particle characterized by a phospholipid: pro- 
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cathode on agar gel and toward the anode on agarose gel, starch gel, or paper electrophoresis (4, 6) . This is true for LP-X in whole plasma as well as for isolated LP-X.
After a rapid and very sensitive immunologic test system was introduced for determining LP-X in whole plasma or serum (10) Many such erroneous diagnoses are recorded in the literature.
Materials and Methods
A total of 2680 LP-X determinations were made on the serum of 1481 subjects. in relation to special questions, all those in whom histologic or other anatomical findings were available.
The LP-X test was performed as previously described (10) . The blood was usually drawn after an overnight fast, allowed to clot, and the serum separated by low-speed centrifugation.
Immunoelectrophoresis was performed in a 1 g/100 ml "BactoAgar" gel (Difco Labs., Detroit, Mich. 48232), with use of barbital buffer (pH 8.6, 50 mmol/liter). The agar-buffer mixture was boiled for 20 mm in a water bath, allowed to cool to 55#{176}C, and 36 ml of the gel was applied to one slide frame (LKB, Bromma, Sweden) for electrophoresis carrying six glass plates, 2.5
x 8 cm. Before electrophoresis the gel plates were stored for at least 6 h in a moist chamber at room temperature.
A total of six antigen wells with a diameter of 2.5 mm were punched ( Figure  2 ) in each slide (per frame, a total of 36) and about 10 l of the patients' sera was applied. When there is an immunoprecipitin reaction to the left (toward the cathode) of the antigen well, LP-X is positive (Figure 2, P) . If this characteristic precipitin reaction for LP-X is absent (Figure 2,  N rum and avoids an eicess of antiserum, which may be important for serum with an extremely low LP-X concentration.
The specific rabbit antisera to LP-X we used were prepared in this laboratory as described previously (4), but antiserum to LP-X is now commercially were LP-X positive. The incidence of cholestasis associated with hepatitis ranges from 5% to more than 50% (12) (13) (14) , the percentages appearing to vary in different epidemics. Therefore, the figure of 26% presumably is representative of our own series only. It is nevertheless remarkable that 65% of our patients with hepatitis had supranormal alkaline phosphatase activities.
In patients without liver disease the LP-X test was invariably negative ( Table 2) . 90% of the patients domized groups of 17 subjects for alkaline phosphatase (Figure 3a) , for alanine transaminase ( Figure  3b) , and for bilirubin (Figure 3c ) with a confidence interval of a = 0.95. The overlap of the confidence intervals shows that it is not possible to distinguish between cholestasis and noncholestasis by using one of these assays as the criterion. Table 3 All determinations on these patients, including the determination of LP-X, were performed on the same day 
